Related Experiment Video
Updated: Jan 29, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Contemporary treatment strategies for Type 2 diabetes-related macrovascular disease
Andrew Mn Walker1, Richard M Cubbon1, Mark T Kearney
1a Leeds Multidisciplinary Cardiovascular Research Centre, LIGHT laboratories, The University of Leeds, Clarendon Way, Leeds, LS2 9JT, UK.
Insights
Type 2 diabetes significantly increases cardiovascular risks, yet current glucose-lowering drugs offer no macrovascular benefit. New treatments targeting underlying pathological processes are needed to reduce cardiac mortality in these patients.
Area of Science:
- Cardiology
- Endocrinology
- Metabolic Diseases
Background:
- Type 2 diabetes mellitus (T2DM) prevalence is rising globally, posing a significant healthcare challenge.
- T2DM doubles the risk of cardiovascular morbidity and mortality, with cardiac causes accounting for 70% of deaths.
- Current glucose-lowering therapies have not demonstrated efficacy in reducing macrovascular events in T2DM patients.
Purpose of the Study:
- To review the cardiovascular risks associated with T2DM.
- To evaluate the effectiveness of current T2DM treatments on macrovascular outcomes.
- To explore novel therapeutic targets for cardiovascular complications in T2DM.
Main Methods:
- Review of large clinical trials on glucose-lowering therapies for T2DM.
- Analysis of established cardiovascular risk reduction strategies in T2DM (blood pressure control, ACE inhibitors, statins).
- Examination of emerging research on pathological processes in insulin resistance.
Main Results:
- Standard glucose-lowering treatments do not reduce macrovascular event risk in T2DM.
- Blood pressure control, ACE inhibitors, and statins are beneficial for cardiovascular risk reduction in T2DM.
- Pathological mechanisms like endothelial dysfunction and oxidative stress are key in T2DM complications.
Conclusions:
- Effective management of T2DM cardiovascular risk requires a multi-faceted approach beyond glycemic control.
- Understanding insulin resistance's pathological pathways offers promise for future cardiovascular therapies.
- Targeting endothelial dysfunction, oxidative stress, and vascular repair may mitigate T2DM-related cardiac events.
Abstract:
Type 2 diabetes mellitus poses a major challenge to healthcare providers in the coming years as its prevalence increases across the globe. The disease doubles the risk of cardiovascular morbidity and mortality, with 70% of sufferers dying from a cardiac cause. Large clinical trials of current glucose-lowering therapies for Type 2 diabetes have shown no benefit in reducing the risk of macrovascular events. Blood pressure control, angiotensin-converting enzyme inhibitor therapy and improvement of dyslipidemia with statins have proven benefit in reducing cardiovascular risk in Type 2 diabetes. A growing understanding of the importance of pathological processes including endothelial dysfunction, abnormal growth factor biology, oxidative stress, dysregulation of adipokines and deficient vascular repair and regeneration in insulin-resistant states promises new treatments to combat the problem.
More Related Videos
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Treatment Strategies for Psychological Disorders
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Alzheimer's Disease: Treatment
Contemporary Psychology
Biopsychology
Biopsychology, also known as biological psychology or behavioral neuroscience, focuses on the biological underpinnings of behavior and mental processes. It...

